S. 1256: Preventing Antibiotic Resistance Act of 2013

Jun 27, 2013
Referred to Committee
0% chance of being enacted
Track this bill
Dianne Feinstein
Senior Senator from California
Read Text »
Last Updated
Jun 27, 2013
22 pages
Related Bills
H.R. 1150 (Related)
Preservation of Antibiotics for Medical Treatment Act of 2013

Referred to Committee
Last Action: Mar 14, 2013


This bill was assigned to a congressional committee on June 27, 2013, which will consider it before possibly sending it on to the House or Senate as a whole.

Introduced Jun 27, 2013
Referred to Committee Jun 27, 2013
Reported by Committee ...
Passed Senate ...
Passed House ...
Signed by the President ...

2% chance of getting past committee.
0% chance of being enacted.

Only 11% of bills made it past committee and only about 3% were enacted in 2011–2013. [show factors | methodology]

Full Title

A bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases.


No summaries available.

8 cosponsors (7D, 1R) (show)

Senate Health, Education, Labor, and Pensions

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Preventing Antibiotic Resistance Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to require an applicant for approval of a new animal drug that is a medically important antimicrobial to demonstrate that there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug.
Requires the Secretary of Health and Human Services (HHS) to refuse approval if the applicant fails to make such a demonstration.
Defines “medically important antimicrobial” as a drug intended for use in food-producing animals and composed wholly or partly of: (1) any kind of specified antibiotics, including penicillin and tetracycline; or (2) a drug from an antimicrobial class that is listed on the World Health Organization’s list of critically important antimicrobials.
Requires the Secretary to withdraw approval for the nontherapeutic use in food-producing animals of a medically important microbial marketed for human use unless the Secretary makes a final written determination that, based on either the application holder's demonstration or an HHS risk analysis, there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance attributable to the drug's nontherapeutic use.
Requires the Secretary to rescind approval of an exemption for investigational use of, or of approval of a new drug application for, a medically important antimicrobial for its nontherapeutic use in a food-producing animal two years after the exemption is granted or the application for approval is submitted. Exempts from this requirement any drugs for which there has been found a reasonable certainty of no harm to human health.
Prohibits the administration of a medically important antimicrobial (including by means of animal feed) to a food-producing animal for nonroutine disease control unless there is a significant risk that a disease or infection present on the premises will be transmitted to the food-producing animal.
Requires the administration of the microbial to be:
(1) necessary to prevent or reduce the risk of transmission;
(2) for the shortest duration possible to prevent or reduce the risk of transmission; and
(3) at a scale no greater than the barn, house, or pen level and to the fewest animals possible to prevent or reduce the risk of transmission.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 1256 with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus